Amentum Holdings, Inc. AMTM | NYSE

$21.97 $0.28 | 1.27%

Next Earnings: May 07, 2025

Company Overview:

Market Cap: $5.34B
PE Ratio: -183.04
52-Week Range: $16.01 - $34.50

0.6 Year Performance Metrics:

Total Return (with DRIP): -25.18% (-38.33% / yr)
Total Return (no DRIP): -25.18% (-38.33% / yr)
Share Price: -25.18%
AMTM Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

AMTM Earnings, Revenue, Cash & Debt, Shares Outstaning:

AMTM - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
AMTM - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
AMTM - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
AMTM - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
AMTM - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
AMTM - Cash & Debt
14-Day FREE Trial Get Full Access Now!
AMTM - Revenue
14-Day FREE Trial Get Full Access Now!
AMTM Revenue CAGR:1Y: 150.62%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
AMTM EPS CAGR:1Y: -61.11%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Net Income
14-Day FREE Trial Get Full Access Now!
AMTM Net Income CAGR:1Y: 6.15%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - EBITDA
14-Day FREE Trial Get Full Access Now!
AMTM EBITDA CAGR:1Y: 25.71%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
AMTM Free Cash Flow CAGR:1Y: 59.42%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
AMTM Free Cash Flow / Share CAGR:1Y: -40.96%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Gross Profit
14-Day FREE Trial Get Full Access Now!
AMTM Gross Profit CAGR:1Y: 86.08%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Expenses
14-Day FREE Trial Get Full Access Now!
AMTM Expenses CAGR:1Y: -100.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
AMTM Shares Outstanding CAGR:1Y: 170.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Share Buybacks
14-Day FREE Trial Get Full Access Now!
AMTM Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
AMTM Stock-Based Comp CAGR:1Y: 200.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

AMTM - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
AMTM Actual Revenue CAGR:1Y: 150.62%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
AMTM Actual EPS CAGR:1Y: -61.11%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
AMTM Actual Net Income CAGR:1Y: 6.15%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
AMTM Actual EBITDA CAGR:1Y: 25.71%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

AMTM - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
AMTM Net Profit Margin CAGR:1Y: -57.65%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
AMTM Gross Profit Margin CAGR:1Y: -25.72%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AMTM - Price to Earnings
14-Day FREE Trial Get Full Access Now!
AMTM - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
AMTM - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
AMTM - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for AMTM

Based on past 0.6-year performance, here are AMTM growth metrics:

Share price CAGR of -38.33%
Dividend CAGR of +0%

Using AMTM CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

AMTM (DRIP)AMTM - No DRIP
Current Price$22.08$22.08
Start Shares452.90452.90
Start Value$10,000$10,000
  
After 10 years:
Final Share Count452.90452.90
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$0.28$22.08
Total Dividends$0$0
Final Value$129$10,000

Estimated Future Value + Dividends - AMTM

NOTE: Above numbers are our estimate based on AMTM's Dividend and Price CAGR over past 0.6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Amentum Holdings, Inc. (AMTM) had its IPO on , and is trader on NYSE stock exchange.

Website - not listed.


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial